Taking the pulse of healthcare and life sciences legal developments
- AI Meets Regulation: At the intersection of EU’s AI Act and Pharma Compliance Strategy Could unchecked AI decide who lives and who doesn’t? The EU’s AI Act is rewriting the rules to make sure this doesn't happen. We are helping client in the healthcare and life sciences sector reshape their compliance strategies. Read our insights in the latest blog. Patrice Navarro Partner 3 November 2025 Read more
- Key insights from HETHICO 2025: Navigating compliance, AI, and ESG in the Healthcare and Life Sciences sector Clifford Chance was one of the proud sponsors of the HETHICO Conference 2025 in Brussels, an event organised by EFPIA, MedTech Europe, and ETHICS. In this blog, our team reflects on how clients in the sector address new regulatory and ethical challenges. Bastien Pavec Avocat 17 November 2025 Read more
- Healthcare Restructuring: What to watch as market pressures intensify Restructuring in healthcare is no longer niche but a strategic reality. As market pressures intensify, clients need to understand the dynamics to mitigate risk and anticipate change. In this latest blog, we explore legal strategies for staying ahead of disruption. Melissa Coakley Partner 10 November 2025 Read more
- The EU Biotech Act: Leveling the Playing Field? The EU’s forthcoming Biotech Act could transform the sector, simplifying rules and boosting funding. Early signals suggest SMEs will benefit, with a fairer path to market and this will strengthen Europe’s biotech edge. Learn how in this blog post. Gunnar Sachs Partner 24 November 2025 Read more
- Joint Clinical Assessments Are Changing the Game for Pharma Launches in Europe The EU’s new Health Technology Assessments Framework is more than regulatory reform. It offers a rare opportunity to simplify compliance, accelerate market access, and shape cross-border legal strategy. Manuela Steininger Associate 1 December 2025 Read more
- EU Pharma Reform nears the finish line – EU institutions reach agreement The EU Pharma Package is the first complete overhaul of EU pharmaceutical rules in more than twenty years. In this blog we start to unpack what this will mean for our clients. Torsten Syrbe Partner, Co-Chair of Healthcare & Life Sciences 12 December 2025 Read more
